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Each year, more than 76,000 new cases of mela-noma are diagnosed in the United States.1 Pe-diatric melanomas account for 0.7% of all cases 
and 0.1% of subsequent mortalities. The incidence of 
pediatric melanoma rises 2.6% annually, which may 
be partially explained by changes in sun-related be-
havior, yet the use of tanning beds and increases in 
ultraviolet exposure do not account for rises in prepu-
bertal populations.1–3 As the number of children diag-
nosed with melanoma continues to rise, accurate and 
timely diagnosis and treatment becomes even more 
paramount. Clinical suspicion remains the corner-
stone of diagnosis and depends on an appreciation 
of the unique clinical features of pediatric melanoma.
Risk factors for melanoma common to both pedi-
atric and adult populations include Fitzpatrick 1 skin 
phenotype, positive family history, previous malignan-
cies, concomitant medical conditions such as xeroder-
ma pigmentosum, and chronic immunosuppression.3,4 
In contrast to established risk factors for adults, sun ex-
posure does not correlate with prepubertal, pediatric 
melanoma. Rates of disease are highest in areas of low 
ultraviolet-B exposure based on geographic location 
in that patient population.1–3 The incidence of mela-
noma in adolescents, on the other hand, more closely 
mirrors the adult melanoma population correlation 
with increased ultraviolet-B exposure.
Traditional detection criteria used in adults often 
fail to identify malignant lesions in children. Suspi-
cious clinical findings in children include amelanosis, 
bleeding, raised lesions, color uniformity, and de novo 
lesion development.3,5 Furthermore, classic prognos-
tic features, including tumor depth of invasion and 
lymph node involvement, less clearly impact survival 
in children.6,7 We report on a case of melanoma in 
a 3-year-old patient to address the clinical features of 
this disease in the pediatric population and review 
some of the factors used to guide treatment options.
CLINICAL	REPORT
A 3-year-old African American girl was referred to 
our office at the request of her dermatologist for a de 
novo, suspicious lower extremity lesion. On physical 
examination, she demonstrated a 0.6 × 0.5 cm, raised, 
darkly pigmented, well circumscribed anterior right 
knee lesion (Fig. 1). There was no ulceration, bleed-
ing, or surrounding skin changes. The patient was 
healthy. She had no medical conditions and took 
no medications, and there was no personal or fam-
ily history of skin cancer. An excisional biopsy was 
performed with wide local excision. Histologic evalu-
ation demonstrated malignant melanoma, nevoid 
type, with a 4.95 mm tumor depth (T4) characterized 
Disclosure: The authors have no financial interest 
to declare in relation to the content of this article. The 
Article Processing Charge was paid for by the authors.
A Case of Pediatric Melanoma: Treatment 
Considerations in Advanced Disease
From the Division of Plastic Surgery, Children’s National 
Health System, Washington, D.C.
Received for publication December 22, 2014; accepted March 
27, 2015.
Copyright © 2015 The Authors. Published by Wolters 
Kluwer Health, Inc. on behalf of The American Society of 
Plastic Surgeons. All rights reserved. This is an open-access 
article distributed under the terms of the Creative Commons 
Attribution-NonCommercial-NoDerivatives 3.0 License, 
where it is permissible to download and share the work 
provided it is properly cited. The work cannot be changed in 
any way or used commercially.
DOI: 10.1097/GOX.0000000000000370
Albino et al.
Frank P. Albino, MD
Benjamin C. Wood, MD
Albert Oh, MD
Gary F. Rogers, MD, JD, MBA, 
MPH
Tina Sauerhammer, MD
Summary: We document a 3-year-old healthy African American girl who 
developed malignant melanoma on her lower extremity. The clinical 
appearance offered little indication of the lesion’s severity (T4), and only 
the history of de novo presentation and disproportionate growth raised 
clinical suspicion. This case report highlights the subtle clinical findings 
of this condition and presents controversies related to surgical manage-
ment of pediatric melanoma. (Plast Reconstr Surg Glob Open 2015;3:e402; 
doi: 10.1097/GOX.0000000000000370; Published online 18 May 2015.)
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by high mitotic activity, poor maturation, and junc-
tional/dermal proliferation of atypical melanocytes 
(Fig. 2). Immunohistochemical staining established 
loss of p16 expression.
The patient returned to the operating room 3 
weeks later for lymphoscintigraphy using 0.4 mCi of 
technetium 99m injected in 4 doses along the previous 
surgical scar. A single sentinel lymph node was identi-
fied and removed immediately preceding a longitudi-
nal reexcision of the biopsy scar with a 2-cm margin 
and primary closure. Unfortunately, the sentinel node 
was positive for a focus of metastatic disease, and ulti-
mately, the patient underwent radical groin dissection, 
which was negative for any residual nodal involvement.
DISCUSSION
In contrast to the established diagnostic, thera-
peutic, and prognostic criteria for adult melanoma, 
the clinical features of pediatric melanoma are poorly 
characterized. Traditional “ABCD” detection crite-
ria must be expanded for pediatric screening to in-
clude amelanosis, color uniformity, and newly arising 
lesions.5 Diagnosing pediatric melanoma is further 
complicated by histologic similarities with some forms 
of benign melanocyte proliferation. Large congeni-
tal melanocytic nevi (CMN) remain a main risk fac-
tor for pediatric melanoma; patients with CMN have 
a 52% higher risk of melanoma compared with the 
general population. This risk is greatest for patients 
with large CMN of the trunk, lesions greater than 
20 cm, and multiple satellite nevi.8,9 Moreover, 16% of 
melanomas are initially misdiagnosed as Spitz nevi.1,4 
Lymph node biopsies have been advocated to aid in 
obtaining the correct diagnosis.7 Gill et al10 found that 
B-RAF, N-RAS, and H-RAS mutations are unique to 
spitzoid melanomas compared with the Spitz nevi.1
In the adult population, sentinel lymph node bi-
opsy (SLNP) is an important staging procedure with 
prognostic implications.6,7,11,12 The prognostic role of 
SLNB for pediatric melanoma has not yet been de-
termined. Roaten et al6 have demonstrated, however, 
that SLNB correlates with tumor depth and is safe 
without mortalities or recurrences over 35 months of 
follow-up. By contrast, the adult cohort of this study 
had fewer cases of sentinel lymph node involvement 
(18%) but overall fared worse with a 25% recurrence 
rate and 9% mortality rate within 19 months from 
their SLNB.6 Whether there is a greater propensity 
for nodal metastasis, a delay in clinical diagnosis, 
or another explanation, remains to be determined; 
however, pediatric melanoma frequently involves lo-
cal lymph node basins. The prognostic implications 
for a positive SLNB on recurrence and survival are 
either not supported or not yet established.5–7,13 Once 
nodal involvement has been established, the need for 
further therapeutic intervention remains unclear. It 
is important to carefully discuss the known morbidity 
of completion lymph node dissection (CLND) in the 
context of its undetermined benefit. Fourteen per-
cent of patients with a positive sentinel lymph node 
Fig. 1. three-year-old girl with right anterior knee lesion.
Fig. 2. Digital photograph of the lesion visualized with hema-
toxylin and eosin stain with high mitotic activity, poor cellular 
maturation, and atypical melanocytes (×20 magnification).
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will have residual tumor draining to their lymph node 
basin, which may be detected by CLND.7 Complica-
tion rates following CLND approach 60%, including 
lymphedema (19–28%) and infection (17–28%).7,13 
As with SLNB, the benefit of CLND for pediatric 
melanoma is largely unknown. To extrapolate from 
adult data, however, 5-year survival rates are higher 
following immediate CLND (72.3%) in patients with 
node-positive disease compared with delayed lymph-
adenectomy when clinically apparent regional node 
metastasis develop (52.4%).11
Our patient with stage III melanoma and node-
positive T4 tumor bears a 5-year survival rate estimated 
at 77%. Nevertheless, her age and the absence of 
 tumor ulceration may prove more favorable char-
acteristics that improve her prognosis.4 The family 
elected to pursue a CLND despite a candid discus-
sion about the minor risks involved with the proce-
dure and the inconclusive benefits of the procedure. 
Her procedure went well and she is undergoing 
medical adjuvant treatment of her cancer. As addi-
tional cases of pediatric melanoma arise, long-term 
outcomes need to be evaluated to determine the 
appropriate surgical management of these tumors to 
most accurately counsel patients and their families. 
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